MaetzelA, LiL. The economic burden of low back pain: A review of studies published between 1996 and 2001. Best Pract Clin Rheumatol, 2002; 16:23–30.
3.
MehraM, HillK, NichollD, SchadrackJ: The burden of chronic low back pain with and without a neuropathic component: A healthcare resource use and cost analysis. J Med Econ, 2012; 15:245–252.
4.
Coxib and traditional NSAID Trialists' (CNT) Collaboration. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: Meta-analyses of individual participant data from randomised trials. Lancet, 2013; 382:769–779.
5.
ChouR. Pharmacologic management of low back pain. Drugs, 2010; 70:387–402.
6.
MasonL, MooreA, DerryS, et al. Systematic review of topical capsaicin for the treatment of chronic pain. BMJ, 2004; 328:991.
7.
GagnierJJ, van TulderMW, BermanBM, BombardierC. Herbal medicine for low back pain. Cochrane Database Syst Rev, 2006; CD004504.
8.
RubinsteinSM, van MiddelkoopM, KuijpersT, et al. A systematic review on the effectiveness of complementary and alternative medicine for chronic non-specific low-back pain. Eur Spine J, 2010; 19:1213–1228.
9.
BuckleJane. Clinical Aromatherapy: Essential Oils in Practice. 2nd ed. New York: Churchill Livingstone. 2003; 90–91.
10.
GubaR. Toxicity myths: The actual risk of essential oil use. Int J Aromather, 2000; 10:37–49.